RecruitingNCT07135323
AvertD follow-up study of device performance and prescribing
About this title
Read the official source — NCT07135323Observational studyAges 18+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- IndianapolisSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 15, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 4,000
- Sponsor
- Prescient Medicine Holdings, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Observational
- Intervention type
- GENETIC
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT07135323
- Official title
Show the full official title
AvertD Post-Approval Study
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Indianapolis
Questions about this study
Who is behind this study?
The study sponsor is Prescient Medicine Holdings, Inc., a pharmaceutical company.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
